InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,346.99
(
-0.11%
)
US TECH 100
18,488.00
(
-0.25%
)
Dow Jones
38,798.99
(
-0.22%
)
Brent Oil
79.40
(
0.00%
)
Bitcoin
69,418.86
(
0.13%
)
Post# of 252107
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

bxjwn9ru

Send PM Follow Ignore
Followers 0
Posts 135
Boards Moderated 0
Alias Born 05/24/2007

bxjwn9ru

Re: None

Tuesday, 09/25/2012 6:00:48 AM

Tuesday, September 25, 2012 6:00:48 AM

Post# of 252107
RIGL - Speaking of the RA market...

Rigel has their Phase 2b mono-therapy study data due before year end and their 3 pivotal Phase 3 studies data due 1H 2013. Also a couple of other compounds in Phase 2 testing with large markets. With an EV of just over $500m this one looks like a decent R/R play. Anyone care to comment?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up